Emerging therapies for endometriosis
Reflections
Published
VOLUME 115, ISSUE 2, P317-318
Author:
Hugh S. Taylor, M.D.
Abstract:
Reflections on "Relugolix, an oral GnRH receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study" by Osuga et al.